TSXV:LBL.H - Post by User
Post by
nothinghereon Feb 03, 2021 12:00pm
146 Views
Post# 32458822
From a previous poster
From a previous poster I follow the industry, known Guy since his Bacterin days. I'm a little long on Lattice for fun. Hey, Guy could get enough suckers in again to get this up. Lattice doesn't belong in that article/report as their total revenue (let alone soft tissue) is a fraction of others mentioned.
Let's review the facts:
2016-2017 - Lattice leaves AZ. Rumor is that they are barely able to get their equipment out before the facilities were padlocked
2018 - stock price bottoms out ($.002 USD), hasn't recovered since (multiple failed growth campaigns)
2019 - slight glimmer of growth and stability in bone products
(Pre-pandemic) 2020 - decreased margins, Guy converts about $1M of debt owed to him by the company into stock.
March 2020 - stock pump scheme around unsupported claims with Amnioboost and Covid
July 2020 - FDA guidance released that amniotic fluid is no longer regulated as a 361 product. This essentially makes Lattice's only potential source of growth non-investable
September 2020 - FDA warning letter issued. Rumor is that they cannot sell legally into the state of FL (check certifications on their website)
You have to respect his tenacity, but they call him Guy Crook for a reason ;)